| Literature DB >> 34508028 |
Varna R Jammula1, Heather Leeper1, Mark R Gilbert1, Diane Cooper2, Terri S Armstrong1.
Abstract
Cognitive reserve (CR) has been proposed to account for functional outcome differences in brain pathology and its clinical manifestations. The purpose of our paper is to systematically review the effects of CR on cognitive outcomes in individuals with neurodegenerative and structural CNS diseases. We performed a systematic search of PubMed, CINAHL (Cumulative Index to Nursing and Allied Health Literature), and PsychInfo using the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. Seventeen studies met the predetermined inclusion criteria and were selected for review. Education level was the most commonly used measure for CR, and various neuropsychological tests were used to measure cognitive outcomes. Regardless of the CNS disease of the individuals, almost all of the studies reported a positive association between CR and cognitive outcomes when they were evaluated cross-sectionally. However, when evaluated longitudinally, CR had either no effect on, or a negative association with, cognitive outcomes. Based on studies across a broad spectrum of CNS diseases, our findings suggest that CR may serve as a predictor of cognitive outcomes in individuals with CNS diseases. However, studies to date are limited by a lack of imaging analyses and standardized assessment strategies. The ability to use a standardized measure to assess the longitudinal effects of CR may allow for the development of more targeted treatment methods, resulting in improved disease outcomes for individuals.Entities:
Mesh:
Year: 2021 PMID: 34508028 PMCID: PMC8635253 DOI: 10.1097/WNN.0000000000000282
Source DB: PubMed Journal: Cogn Behav Neurol ISSN: 1543-3633 Impact factor: 1.600
FIGURE 1PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow diagram of our systemic review on the effects of cognitive reserve on functional outcomes of CNS diseases.
Review of Cognitive Reserve Studies
| Reference | Population & Sample | Primary Objective | Study Design & Instruments | Key Findings & Limitations |
|---|---|---|---|---|
|
| 35 participants M age = 76 77% male Individuals with PD without dementia Italy | To investigate how CR influences cognitive performance in participants with PD without dementia |
|
|
|
| 37 participants M age = 69 years 70% male Individuals with behavioral variant frontotemporal dementia Italy | To investigate the effect of occupation on brain functional reserve in participants with behavioral variant frontotemporal dementia |
|
|
|
| 121 participants M age = 41 years 59% male Individuals diagnosed with uncomplicated mild TBI (n = 75) and complicated mild to severe TBI (n = 46) Assessed within 1–12 months post injury United States | To determine the protective role of CR in relation to psychometric intelligence after TBI |
|
|
|
| 663 participants M age = 66 years 49% male Individuals who were AD biomarker-positive with dementia (n = 462) or in predementia stages (n = 201) Amsterdam | To examine cross-sectional effects of CR and BR on cognition in participants with AD |
|
|
|
| 50 participants Ages 35–89 years (M = 70) 72% male Individuals diagnosed with PD Grouped by low disease duration (1–9 years) and medium to high disease duration (>9 years) Italy | To evaluate the association of CR with cognition and motor functions of participants with PD at different stages of disease |
|
|
|
| 525 participants Ages 32–94 years (M = 68) 65% male Individuals with PD 195 participants were lost to follow-up United Kingdom | To examine the effects of CR on cognition and cognitive decline in individuals with PD |
|
|
|
| 10,475 participants M age = 80 40% male Individuals with AD and related dementias Not placed in residential care before initial assessment Assessed from 0–30 months before residential care placement Canada | To examine how cognitive functioning in AD and related dementias changes over time and its relationship to education levels and the relationship between SMMSE ( |
|
|
|
| 48 participants M age = 63 58% male Individuals with PD The Netherlands | To determine to what extent CR influences cognition in participants with PD |
|
|
|
| 61 participants Ages 18–65 years (M = 41) 75% male Individuals with complicated mild to severe TBI ≥1 year post injury United States | To verify cognitive evidence of CR in individuals with TBI and to extend prior research by investigating CR’s moderating effects |
|
|
|
| 100 participants Average age = 47 63% male Individuals with mild TBI (n = 58), moderate TBI (n = 25), and severe TBI (n = 17) ≥1 year post injury United States | To investigate the relation between factors of CR and post TBI neuropsychological and functional outcomes |
|
|
|
| 228 participants M age = 46 years Individuals with lesion to frontal region from stroke (n = 22) or brain tumor (n = 64) and HC (n = 142) United Kingdom | To investigate the independent effects of education and NART IQ on cognitive outcomes in participants with focal, unilateral frontal lesions |
|
|
|
| 54 participants M age = 73 years 43% male Individuals with AD dementia (n = 36) and with resilience to AD dementia based on pathology (n = 18) Resilience indicated the individual was in a prodromal phase of neurodegeneration United States | To test proxies of CR and BR and determine their association with cognitive function in AD pathology |
|
|
|
| 122 participants Age = 15–65 years (M = 37) 57% male Individuals with mild TBI assessed at baseline within 24 hours after trauma HC (n = 35) recruited at follow-up Sweden | To investigate the association between cognitive performance and postconcussion symptoms in relation to CR |
|
|
|
| 145 participants M age = 61 years 59% male Individuals diagnosed with frontotemporal lobar degeneration (n = 55) and demographically matched HC (n = 90) United States | To evaluate if CR contributes to differences in frontal gray matter density and executive impairment in the disease course of frontotemporal lobar degeneration |
|
|
|
| 50 participants Average age = 38 years 74% male Individuals with moderate to severe TBI ≥1 year post injury United States | To investigate the link between CR and long-term memory impairment due to TBI |
|
|
|
| 303 participants M age = 57 years 42% male Individuals with AD biomarkers United States | To examine the association between CR, biomarker levels of AD, and the long-term cognitive trajectories |
|
|
|
| 175 participants Age = 19–79 years (M = 35) 61% male Individuals with TBI (n = 109) and demographically matched controls (n = 66) Assessed within 2–6 weeks post injury and at 6 and 12 months post injury United States | To assess whether CR predicts cognitive outcomes post TBI and the rate of recovery |
|
|
Complete references for all tests are provided in the References section.
AC E–R = Addenbrooke’s Cognitive Examination Revised. AD = Alzheimer disease. BR = brain reserve. BVMT = Brief Visuospatial Memory Test. CR = cognitive reserve. CRI = Cognitive Reserve Index. CVLT = California Verbal Learning Test. DSB = Digit Span Backward. DSF = Digit Span Forward. MCI = mild cognitive impairment. FAB = Frontal Assessment Battery. HC = healthy controls. MCI = mild cognitive impairment. MMSE = Mini-Mental State Examination. NART = National Adult Reading Test. PASAT = Paced Auditory Serial Addition Test. PD = Parkinson disease. PEG = Grooved Pegboard Test. RAPM = Raven’s Advanced Progressive Matrices. RAVLT = Rey Auditory Verbal Learning Test. RCPM = Raven’s Coloured Progressive Matrices. RPQ = Rivermead Post Concussion Symptoms Questionnaire. SMMSE = Standardized Mini-Mental State Examination. TBI = traumatic brain injury. TMT = Trail Making Test. WAIS = Wechsler Adult Intelligence Scale. WMS = Wechsler Memory Scale. WTAR = Wechsler Test of Adult Reading.
Risk of Bias Assessment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cases are representative | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Initial numbers accounted for | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + |
| Appropriate diagnostic criteria | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + |
| Controls screened using same diagnostic criteria | NA | NA | NA | + | NA | NA | NA | NA | NA | NA | + | + | + | + | NA | NA | + |
| Screening for psychiatric disorders | + | – | + | + | – | – | – | – | + | – | + | – | + | – | – | – | + |
| Outcome assessors blinded to group status | NA | NA | NA | – | NA | NA | NA | NA | NA | NA | – | – | – | – | NA | NA | – |
| Controlled for cofounding variables | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + |
| Appropriate subgroup evaluation | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + |
| Missing data | – | – | + | + | + | + | + | – | – | + | + | + | + | – | – | + | + |
| Appropriate methods to deal with missing data | NA | NA | + | + | + | + | + | NA | NA | + | + | + | + | NA | NA | + | + |
| All outcomes and groups reported | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + |
| Valid cognitive measures | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + |
| Reliable cognitive measures | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + |
+ = yes. – = no. NA = not applicable.